T1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
1996 • 2,410 citations
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
1993 • 1,908 citations
Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis
1998 • 931 citations
Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
1999 • 713 citations
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
1998 • 652 citations
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
1999 • 467 citations
Accumulation of hypointense lesions ("black holes") on T 1 spin-echo MRI correlates with disease progression in multiple sclerosis
1996 • 451 citations
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
1996 • 444 citations
Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-?1a in relapsing-remitting multiple sclerosis
1999 • 384 citations
Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR.
1998 • 266 citations
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis
2000 • 236 citations
Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H
1999 • 218 citations
Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy
1999 • 205 citations
Effect of interferon-?1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: Results of a European multicenter, randomized, double-blind, placebo-controlled trial
1999 • 158 citations
Histopathological Characterization of Magnetic Resonance Imaging-Detectable Brain White Matter Lesions in a Primate Model of Multiple Sclerosis
1998 • 145 citations
Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations
2000 • 136 citations
A longitudinal study of T1 hypointense lesions in relapsing MS
2000 • 134 citations
Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis.
1999 • 102 citations
Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images.
1999 • 79 citations
The effect of cladribine on T1 ‘black hole’ changes in progressive MS
2000 • 60 citations
Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging
1998 • 53 citations
T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation
1998 • 44 citations
Interferon-beta -1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images
1999 • 28 citations
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results
1999 • 28 citations
Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon β 1a
1999 • 27 citations
The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurement
2000 • 17 citations
Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.
1995 • 12 citations